ArticleProceedings of the National Academy of Sciences of the United States of America2023

Combined disruption of T cell inflammatory regulators Regnase-1 and Roquin-1 enhances antitumor activity of engineered human T cells.

David Mai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.